SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced an abstract for iza-bren (izalontamab brengitecan), a potentially first-in-class EGFRxHER3 bispecific antibody ...
A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research ...
Imaging studies of more than 27,000 adults link a healthier thymus on CT scans with a longer life and lower risks of ...
Per-protocol survival improved versus earlier cutoffs, with 35% alive beyond 30 months and 13% beyond 50 months after two ...
A Stage 4 lung cancer diagnosis at the height of Covid coincided with the dissolution of my 20-year marriage. The news landed ...
Researchers have discovered that aging may fundamentally reshape how lung cancer spreads. A stress-response protein called ATF4 appears to help tunbsmors metastasize in older patients, pointing to a ...
Retrospective, single-center design and limited power render findings hypothesis-generating, supporting prospective ...
Lindsay talks about the difficult road of managing a pulmonary arterial hypertension diagnosis, and how a newly discovered ...
Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...
HealthDay on MSN
Women more likely to survive cancer than men — at a cost
Key Takeaways Women are more likely to survive cancer than menHowever, they also are more likely to develop severe side ...
In an unexpected result, researchers found lung and skin cancer patients who had received Covid-19 vaccines experienced ...
Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results